VolitionRX (AMEX:VNRX) reported quarterly losses of $(0.97) per share which missed the analyst consensus estimate of $(0.75) by 29.33 percent. This is a 1516.67 percent decrease over losses of $(0.06) per share from the same period last year. The company reported quarterly sales of $985.076 thousand which beat the analyst consensus estimate of $426.600 thousand by 130.91 percent. This is a 299.81 percent increase over sales of $246.385 thousand the same period last year.